Delivery Order SPE2DB20D1004-SPE2DB24FG4T3

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4,563,337,573 units of the medication Ezetimibe 10 mg tablets. The contract has a ceiling value of $7,668.18 and a period of performance through January 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ezetimibe 10 mg tablets. The $2,981.16 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 30, 2025. The contract is a delivery order and does not appear to have any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.23 firm fixed-price delivery order is for the supply of 4562437463 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product, with an ultimate completion date of October 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,356.71, is for the delivery of 500 tablets of the pharmaceutical product Ezetimibe 10 mg. It is a firm fixed-price contract with a completion date of February 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order (SPE2DB24FCQWY) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,436 units of the generic drug Ezetimibe 10 mg tablets. The $2,685.55 firm fixed-price contract has an ultimate completion date of April 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.12 firm fixed-price contract is for the delivery of 4,566,670,756 tablets of the prescription drug ezetimibe 10 mg. The contract has a completion date of December 11, 2024 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,909.70, is to provide 500 tablets of the drug ezetimibe 10 mg. The award has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $3,157.77 firm fixed price delivery order is for the supply of 500 units of the pharmaceutical drug Ezetimibe 10 mg tablets. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP39H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.86 Firm Fixed Price delivery order is for the provision of 4564996823 - EZETIMIBE 10 MG TABLET 500S. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $2,269.98 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of 4564804826 - Ezetimibe 10 mg Tablet 90s. The award has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG4T3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EZETIMIBE 10 MG TABLET 500S. The contract has a firm fixed price of $2,718.04 and a period of performance through July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its ability to deliver a wide array of essential medical commodities.

Generated 2/27/25, 11:13 AM